Approximately eight healthy volunteers came for two visits, with two different formulations. The insulin suppositories showed rapid insulin absorption and reactive glucose lowering effect. The suppositories were well
In her new position, Ms LaBate will be responsible for providing day-to-day oversight and support to all of Genesis’s regional vice presidents of operations and administrators in six
Mr Fletcher has been a director of Neurobiological Technologies since February 2007. With the acting CEO appointment, the board of directors has discontinued its previously announced search for
PrandiMet is a meglitinide and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who
According to the results of an internal review conducted at the clinical site, and a second review by the trial’s independent data safety monitoring board, this event has
In this newly created role, Dr Currie will drive partnering, licensing, companion diagnostics, and corporate business development activities at Sirs-Lab. Dr Currie, a physician specialized in clinical microbiology
Dale VanderPutten, CEO of Omnia Biologics, said: “The team at Omnia is very pleased to have assisted Sumagen in this important effort addressing the new priorities of the
This approval enables the company to begin marketing aegis products for sale in the EU. Peripatch aegis is a buttressing material designed to reinforce the staple line and
The issued patent, expiring in 2024, describes, in part, assays for the detection of methylation within a vimentin nucleotide sequence. Studies have demonstrated that methylation of vimentin DNA
The company expects that the new drug application (NDA) filing, if accepted, will be subject to standard review, which would provide a target for the FDA to complete
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.